There is no single TMS success rate, because success depends on which condition is being treated and which outcome, response or remission, is being measured. Response generally means at least a 50 percent reduction in symptoms; remission means symptoms have dropped to a minimal or absent level. Those two numbers are often very different, and outcome definitions vary further by condition. Here is what the published research actually shows for each of the conditions TMS is used to treat.
What We Know
|
Why success rate depends on the question you ask
Response and remission are not the same outcome, and neither is fixed across studies. Response is typically defined as at least a 50 percent reduction in symptom severity on a standardized scale; remission means scores have dropped close to zero, essentially the resolution of the condition. A treatment can post a high response rate and a much lower remission rate, and both numbers can shift further depending on how many prior treatments a study population had already failed.
Success rates for depression
Across the published literature on TMS therapy for treatment-resistant depression, clinical trial response rates generally land between 50 and 60 percent, with remission around 30 to 40 percent. An NIMH-sponsored, sham-controlled trial is one of the more frequently cited studies establishing this effect: it found meaningfully higher response and remission rates in the active TMS group compared to sham, a comparison that rules out placebo response as the explanation. Some large outcome registries have reported figures on the higher end of this range, with patient-rated response reaching roughly 69 percent and remission around 36 percent in naturalistic, non-trial settings.
Success rates for OCD
TMS for OCD received FDA clearance in 2018 based on a multicenter, sham-controlled trial in which 38 percent of patients receiving active deep TMS achieved a clinically meaningful reduction in OCD symptoms, compared to 11 percent on sham, a response rate roughly 3.5 times higher than sham. Post-marketing, real-world data collected across 22 clinical sites reported a response rate of approximately 58 percent after a full course of treatment, suggesting outcomes outside the controlled trial setting have held up or improved.
Success rates for anxious depression
For depression with significant co-occurring anxiety, the evidence base is smaller than for depression alone, but generally supportive. Research shows that after at least 20 sessions, roughly half of patients experience a meaningful reduction in anxiety symptoms, and about 30 percent reach remission. Success rates tend to run slightly lower than for depression without significant anxiety, reflecting the added complexity of treating two overlapping symptom clusters at once.
What these numbers mean day to day
A 50 to 60 percent response rate means a clear majority of patients notice a meaningful improvement, but it also means a real minority do not, and that gap is worth setting realistic expectations around before starting. A response is also not always a straight line to remission. Many patients land somewhere in between, meaningfully better without being fully symptom-free, which is still a legitimate outcome worth pursuing rather than a partial failure.
Call 646-817-2835 or contact us to book a free consultation.
